Sera Prognostics Adds New Senior Executive
September 22, 2021
Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA) will add a new doc to the team. Dr. Michael R. Foley has been appointed to the position of Chief Medical Officer starting in January 2022.
Salt Lake City-based Sera Prognostics focuses on neonatal health as well as maternal health using biomarker information. Using PreTRM® test reports, physicians can predict individualized risk of spontaneous premature delivery in a pregnancy, making early proactive intervention possible.
Dr. Foley has previously worked in a private maternal-fetal medicine practice for over 20 years as well as Chairman of Obstetrics and Gynecology at the University of Arizona College of Medicine Phoenix/Banner Good Samaritan Regional Medical Center, where he has served for over 1o years.
Recent News
- Nucleus Institute Convergence Point Groundbreaking
- EDWARDS LIFESCIENCES RECEIVES FDA APPROVAL FOR AUTUS VALVE
- Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
- Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards
- BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
